Loss of FOXP1 results in decreased number of bRGCs. by Seon Hye E. Park (16765033)

MVK activates microglia and decreases phagocytosis. by Ren Y. Sato (16914027)

Depletion of putative SDH subunits leads to decreased SDH activity and oxygen consumption. by Mariana F. Silva (10219520)

Inhibition of the mitochondrial fission decreases mtROS production. by Dong Ma (584680)

Subjects:

Demonstration of decreased Aβ accumulation by DA-9601 treatment. by Mijung Lee (397790)

Germ cell size decreases before corpse formation. by Tea Kohlbrenner (19476160)

Mitigation (decreasing) scenario. by Fabio Correddu (12501799)

Viral replication in obese mice results in decreased genetic diversity. by James Weger-Lucarelli (603766)

Rcan2-mediated decrease in intracellular K⁺ involves Kcnk5b. by Xiaowen Jiang (8291814)

DJA2 decreases maturation of CFTR. by Patrick Kim Chiaw (7224539)

Additional behavioral patterns in the 5€, 100€, and 1000€ treatments. by Pablo Brañas-Garza (336425)

VPA decreases cell proliferation. by Muriel Rhinn (406515)

Nicorandil inhibits the decrease of SYP. by Yuanzheng Zhao (10035836)

Delphinidin alters VEGF-A splicing to increase VEGF-A₁₆₅b and decrease total VEGF-A expression. by Megan Stevens (3964886)

“…<p><b>A)</b> Treatment of podocytes with delphinidin chloride (10 μg/ml) under normal glucose (NG; 5 mM glucose + 25 mM mannitol) and high glucose (HG; 30 mM glucose, 1 ng/ml TNFα, 1 ng/ml IL-6, and 100 nM insulin) for 48 hrs increased the protein expression of VEGF-A₁₆₅b relative to total VEGF-A₁₆₅ (quantified in <b>B</b>; *p<0.05 vs NG, †p<0.05 vs HG; n = 3 biological repeats; One-way ANOVA with Bonferroni post-hoc test for comparison between pairs; <b>A</b>—the same blot was first probed with VEGF-A₁₆₅b before stripping and reprobing with panVEGF-A). …”

Metformin/rifampicin combination decreases <i>S</i>. <i>aureus</i> load and persisters in Mice. by Xiao-Qi Lin (9548375)

Decreased Paneth cell number and the presence of granulomas differentiate HbTg from Tg animals at 10 days post Tg infection. by Edina K. Szabo (3160332)

Probability of release is decreased by hydrophobic mutations. by Matthew R. Bowers (8423115)

GSK343 decreased tumor stemness. by Laura V. Bownes (10276762)

“…Treatment with GSK343 significantly decreased tumorsphere formation by both the COA3 (A) and COA6 (B) cells, representing a decrease in stem cell-like phenotype. …”

Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)

AIM-100 reduces dsRNA silencing in body wall muscle and decreases DA neurodegeneration. by Anthony L. Gaeta (13272609)